We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraven House Capital Regulatory News (CRV)

Share Price Information for Craven House Capital (CRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.20
Bid: 0.15
Ask: 0.25
Change: 0.00 (0.00%)
Spread: 0.10 (66.667%)
Open: 0.20
High: 0.20
Low: 0.20
Prev. Close: 0.20
CRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Results for year ended 31 May 2013

29 Nov 2013 07:00

RNS Number : 2401U
Craven House Capital PLC
29 November 2013
 



29 November 2013

 

Craven House Capital Plc

("Craven House" or the "Company")

 

Final Results for the Year Ended 31 May 2013

 

CHAIRMAN'S REPORT

 

Highlights

 

Strong performance in the period with a number of key business objectives achieved:

 

• NAV of holdings increased by 66% from £2.32m to £3.84m

• Investments secured utilising Craven House shares as acquisition currency

• Cash generative asset successfully acquired

 

Overview

 

During the 12 months to 31 May 2013, Craven House Capital Plc ("Craven House") has demonstrated considerable success in building on the solid foundations created by the restructuring of the business during the prior year and our partnership with our investment manager, Desmond Holdings Ltd ("Desmond").

 

We measure Craven House's success on one simple metric: the Net Asset Value of our holdings. We are therefore delighted to report a significant improvement in our NAV as a result of our investment activities over the course of the year, with net assets increased from £2.32million to £3.84million; a 66% year-on-year increase. This is particularly pleasing progress, given that the Company demonstrated a negative asset value the prior year when the current board and Desmond took control of the Company. This has been achieved entirely through the acquisition of new assets and reduction of debt, with no increases made in the carried value of existing assets on the balance sheet. This trend has continued in post balance sheet events, which have further increased the Company's NAV by approximately £2.4million.

 

In addition to the significant increase in NAV, I am very pleased to report success in its two stated goals during the period:

 

• to target acquisitions where we can utilise Craven House shares as acquisition currency, and

• to acquire cash generative assets

 

During the year, we made two sizeable investments in Brazil, acquiring significant stakes in a company which owns a large parcel of agricultural / development land, and a profitable manufacturing business. In both instances, the consideration was paid using Craven House shares.

 

In addition, we acquired a distressed loan, secured by the property of a large business hotel in Dublin. This loan was purchased at a significant discount to its face value and was immediately cash generative.

 

When using our shares as consideration in acquisitions, this year we have once again done all deals at a price of 1.25p per Craven House share, a price significantly above our average share price during this period. This reflects the shared view we hold with those companies in which we have invested, which is that our share price has been, and remains greatly undervalued.

 

Further details of these acquisitions are provided below along with updates of existing investments.

 

Investment Activity & Performance

 

During the period, Craven House made investments in the following companies:

 

· On 24 September 2012, the Company purchased a 49% stake in Ceniako Limited ("Ceniako") for a total consideration of €1,000,000.

 

Ceniako is a Cypriot holding company, whose sole asset is 1,967 hectares of productive agricultural land with significant development potential. Situated directly on the Atlantic coast of Brazil, between Salvador and Rio de Janeiro, the property features over two kilometres of beachfront in addition to productive cattle pastures and cropland. As disclosed in the Company's interim accounts on 28 February 2013, the land has been independently valued at circa EUR€4.5m. We continue to investigate the agricultural potential in order to maximise cash generation from the land, whilst pursuing its development potential and seeking a buyer or development partner for all or part of the site.

 

· On 28 December 2012, the Company acquired, through its 95% subsidiary, Craven House Industries Ltd, a 50.1% stake in Finishtec Acabamentos Técnicos em Metais Ltda. ("Finishtec") for a total consideration of $1,000,000, from the founding partners of Finishtec.

 

Founded in 1998, Finishtec is a Brazilian manufacturing company, based in Curitiba. It specialises in the manufacture of industrial electrical switching, distribution and insulating equipment for the domestic power sector in Brazil. It has a strong track record in the development of new technological practices, and has recently launched a new product line targeting the renewable energy sector. Finishtec benefits from an impressive list of blue-chip clients, which include ABB, Siemens, Alstom, Toshiba and Odebrecht.

 

A key benefit of Craven House's shareholding is that it enables Finishtec to access cheaper short term financing than is available for small companies locally in Brazil. This gives Finishtec a distinct competitive advantage and will enable them to secure larger orders and to enhance profit margins.

 

Finishtec's order book has increased considerably since the time of our investment and we look forward to reporting further progress in due course.

 

· On 28 May 2013, Craven House acquired a distressed loan, secured by way of a mortgage over the 270-room Green Isle Hotel in Dublin. The loan was acquired for a cash consideration of €700,000 and resulted in Craven House becoming the sole secured lender to the hotel. We set out to proactively restructure the hotel's balance sheet to ensure it is able to operate as a profitable going concern in the future. Interest payments due under the terms of the loan mean that this acquisition was immediately cash generative, with the cash used to pay down debt. Further detail on subsequent developments in this investment are set out in the post balance sheet events paragraph below.

 

Craven House provides updates on its positions in the following companies:

 

· Pressfit Holdings Plc ('Pressfit') is a UK holding company with subsidiaries manufacturing specialist stainless steel pipe fittings in China. Craven House's shareholding at the period end represented 36.9% ownership of Pressfit, through investments totalling £1,474,168 with a further 3% of the shares in Pressfit being available to the Company in the event that an outstanding convertible loan is exercised. During the period, Mark Pajak, Director of Craven House and Director of Desmond accepted a position as Chairman of Pressfit.

 

Whilst Pressfit continued to make encouraging progress during the period, with a number of new manufacturing licences and orders being secured, the most notable event occurred after the end of the period. In July 2013, Pressfit entered into a Partnership Agreement with GXM (Amcopress) Group Co., Limited ("AMCO"). AMCO is a large and profitable manufacturing and distribution company, which operates in the same market sector as Pressfit. Under the agreement, AMCO has provided significant new investment into Pressfit as well as offering management expertise and active sales and distribution channels. It has invested £1,575,000 into Pressfit by way of a convertible loan note. Further to the conversion of this loan in September 2013, AMCO now hold 45.1% of Pressfit's enlarged share capital, with Craven House's holding reduced to 20.3% of the enlarged share capital (or 21.6% if Craven House converts its own convertible loan note). 

 

Pressfit has now begun preparations for an introduction to the AIM market with the belief that this will help facilitate expansion and further Pressfit's aim of becoming a major international company specialising in the manufacture and distribution of stainless steel pressfittings.

 

· Farm Lands of Africa Inc. ('FLAF') is a green-field agribusiness operating in West Africa, which is listed on the OTC Markets in New York.

 

Following the merger of FLAF with an Indian-owned Guinean agricultural company in September 2012, a number of investor protection mechanisms were triggered which subsequently enabled Craven House and other minority shareholders of FLAF to negotiate a settlement agreement with FLAF which was finally closed after the period end, in August 2013.

 

As a result, Craven House now owns 50% of Farm Lands of Africa Ltd (BVI) which in turn owns 90% FLAF's original core subsidiary, Land and Resources (Guinea) SA ("LRG"). LRG has the opportunity to control various agricultural assets and operations in the Republic of Guinea, including leases over up to 110,000 hectares of arable land.

 

The outcome of this negotiated settlement is extremely beneficial for Craven House, with its effective holding in LRG increasing from less than 7% to 45%. This also provides Craven House with greater control exposure to the potential value of this asset going forward.

 

· On 21 December 2012, certain non-core investments were exited. Outstanding convertible loans made to Minera Mapsa SA ("Mapsa") and Planteman SA ("Planteman") in 2010 were repaid plus accrued interest (accrued at a rate of 8 per cent. per annum). The Company received $116,667 from Mapsa and $700,000 from Planteman. All cash received was used to pay down debt. 

 

Management and Performance Fee

 

Under the terms of Craven House's Management Services Agreement with its Investment Manager, Desmond is entitled to receive an annual Performance Fee equal to 20% of the increase in the Net Asset Value of the Company during the period, subject to a hurdle rate of at least 5%. In accordance with this agreement, Desmond has been awarded a performance fee of £170,600 for the financial year ending May 2013.

 

Desmond Holdings has opted to receive this fee in shares of Craven House valued at 1.25p per share. We believe this aligns all interests as the management company receives compensation at the same level as investors in the last private placement who subscribed for new shares at 1.25p and portfolio companies, which are acquired using Craven House shares also valued at 1.25p per share.

 

It is noteworthy that Desmond Holdings has purchased additional shares in the market and has never sold a single share of the Company. Additionally, the majority of the board receive any director's fees due in shares issued at a premium to both the current share price and the NAV.

 

Working Capital

 

Operating and overhead costs continue to be managed very prudently and have been significantly reduced as a result of our restructuring. On-going monthly operating costs were circa.£15,000 (inclusive of all management fees), during the period.

 

Immediate working capital needs will be met by cash in the bank, and the continued support of the Company's major shareholder and Investment Manager, Desmond, in the form of both extension of existing loan facilities and new working capital loans where required.

 

The successful acquisition of a cash generative asset during the period and similar acquisitions targeted in the future are expected to significantly reduce the Company's requirement for these working capital facilities going forward. The Company may also seek to execute an additional capital raise when market conditions are suitable for such fundraising activity.

 

Post Balance Sheet Events

 

The settlement agreement with FLAF and approval of Pressfit shareholders to commence an Initial Public Offering, both described above under the heading "Investment Activity and Performance," took place after the period end.

 

On 6th November 2013, the Company announced the acquisition of a 49% shareholding in a portfolio of agricultural and food processing businesses in South Africa, for a total consideration of $1,960,000. This portfolio comprises a 1,017 hectare vegetable and cattle farm, a vegetable dehydration factory and a distribution centre. This investment represents an outstanding opportunity to establish an interest in food production and processing in South Africa, and we look forward to reporting further progress in relation to these assets in due course.

 

The restructuring of the distressed loan on the Green Isle Hotel in Dublin was completed on 21st November 2013. The sale of the Hotel to the new owners was completed, and the Company agreed with the new owners to convert the Loan into a mortgage of €1,500,000 (the "Mortgage"). The Mortgage will carry an interest rate of 4% per annum and will be repaid in full within three years. This transaction is expected to result in an increase of €1,500,000 in the net asset value of Craven House in the next financial year.

 

Outlook

 

The investments made during the period and subsequent activity further demonstrate our ability to execute our strategy of acquiring attractive assets and businesses in our target markets on excellent terms, in particular through the use of Craven House's shares as acquisition currency. We continue to be of the view that our focus on real assets in emerging markets and special situations in developed markets will offer the best returns in the current global economic environment.

 

The Company's balance sheet continues to expand at a rapid pace and the most recent investments offer the potential for short-term cash generation. As Craven House's asset base grows, we are able to target larger acquisition targets with the primary goal of enhancing our shareholders' net asset value per share. We are very confident that in continuing to pursue this strategy, we will be able to secure our shareholders above market returns.

 

Conclusion

 

We remain committed to building long term value for shareholders. We are contrarian by nature, seeking undervalued opportunities where the cost of capital remains high, as most institutions are unable or unwilling to participate. This can be a time consuming process and we pass on over ninety percent of the deals offered to us as we treat our share capital as a precious asset only to be utilised when the returns justify the dilution.

 

We have not invested in promoting our potential, preferring instead to wait until we have a track record which will speak for us, as shown by the recent Green Isle Hotel transaction. However, time is on our side and over the next couple of years, we expect to deliver a number of meaningful exits from the portfolio. This should lead to a re-rating of our shares as the market begins to recognise the intrinsic value of the Company.

 

The management team remains focused on continuing to deliver an increase in net asset value. As our market capitalisation and asset base increases, we will be able to conduct more financially meaningful transactions. We aspire to build a meaningful business grounded in real assets and capable of generating above average returns for the long term.

 

 

Mark Pajak

Acting Chairman

 

Copies of the Company's Annual Report and Accounts for the year ended 31 May 2013 are being posted to shareholders today, together with the notice of the Company's forthcoming Annual General Meeting, to be held at 2.00pm on 6 January 2014 at the offices of Daniel Stewart and Company plc, Becket House, 36 Old Jewry, London EC2R 8DD.

 

The Annual Report and Accounts, and the Notice of Annual General Meeting may be viewed in their entirety on, or downloaded from, the Company's website www.cravenhousecapital.com 

 

 

 For further information please contact:

 

Craven House Capital Plc:

www.cravenhousecapital.com

 

Alexandra Eavis

Non Executive Director & Company Secretary

 

Tel: 07590 831 323

Daniel Stewart & Company Plc:

(Nominated Adviser & Broker)

Antony Legge/James Thomas

Tel: 020 7776 6550

 

 

 

 

INCOME STATEMENTS

FOR THE YEAR ENDED 31 MAY 2013

 

Notes

Group & Company

2013

£'000

 

Company

2012

£'000

CONTINUING OPERATIONS

Revenue

348

34

Gross portfolio return

246

(305)

Other operating income

-

4

Administrative expenses

(989)

(261)

OPERATING LOSS

(395)

(528)

Finance costs

4

(79)

(6)

Finance income

4

28

57

LOSS BEFORE INCOME TAX

5

(446)

(477)

Income tax

6

-

-

LOSS FOR THE YEAR

(446)

(477)

Earnings per share expressed

in pence per share:

7

Basic and Diluted

-0.09

-0.17

 

 

STATEMENTS OF COMPREHENSIVE INCOME

FOR THE YEAR ENDED 31 MAY 2013

 

Group & Company

2013

£'000

 

Company

2012

£'000

LOSS FOR THE YEAR

(446)

(477)

OTHER COMPREHENSIVE INCOME

-

-

TOTAL COMPREHENSIVE INCOME FOR THE YEAR

(446)

(477)

TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO:

Owners of the company

(446)

(477)

Non-controlling interests

-

-

(446)

(477)

 

 

STATEMENTS OF FINANCIAL POSITION

31 MAY 2013

 

 

 

Notes

Group

2013

£'000

Company

2013

£'000

Company

2012

£'000

ASSETS

NON-CURRENT ASSETS

Property, plant and equipment

8

-

-

1

Investment in Subsidiary

-

656

-

Investments at fair value through

profit or loss

9

4,597

3,941

2,886

4,597

4,597

2,887

CURRENT ASSETS

Trade and other receivables

10

79

79

77

Cash and cash equivalents

11

1

1

31

80

80

108

TOTAL ASSETS

4,677

4,677

2,995

EQUITY

SHAREHOLDERS' EQUITY

Called up share capital

12

8,313

8,313

8,016

Share premium

4,948

4,948

3,277

Retained earnings

(9,419)

(9,419)

(8,973)

TOTAL EQUITY

3,842

3,842

2,320

LIABILITIES

CURRENT LIABILITIES

Trade and other payables

13

372

372

82

Financial liabilities-borrowings

interest bearing loans and borrowings

14

463

463

593

835

835

675

TOTAL LIABILITIES

835

835

675

TOTAL EQUITY AND LIABILITIES

4,677

4,677

2,995

 

 

 

STATEMENTS OF CHANGES IN EQUITY

FOR THE YEAR ENDED 31 MAY 2013

 

Called up share capital

£'000

Profit and loss account

£'000

 

Share premium

£'000

 

Total equity

£'000

 

 

Balance at 1 June 2011 - Company

7,915

(8,496)

383

(198)

Changes in equity

Issue of share capital

241

-

2,754

2,995

Total comprehensive income

-

(477)

-

(477)

Balance at 31 May 2012 - Company

8,156

(8,973)

3,137

2,320

Changes in equity

Issue of share capital

157

-

1,811

1,968

Total comprehensive income

-

(446)

-

(446)

Balance at 31 May 2013 - Group & Company

8,313

(9,419)

4,948

3,842

 

 

STATEMENTS OF CASH FLOWS

FOR THE YEAR ENDED 31 MAY 2013

 

 

 

Notes

Group & Company

2013

£'000

 

Company

2012

£'000

Cash flows from operating activities

Cash generated from operations

1

(354)

(420)

Interest paid

(79)

(6)

Finance costs paid

-

-

Net cash from operating activities

(433)

(426)

Cash flows from investing activities

Purchase of tangible fixed assets

-

(2)

Purchase of fixed asset investments

(2,018)

(2,736)

Sale of fixed asset investments

537

61

Other loans

(130)

6

Exchange variance re investments

18

(30)

Interest received

28

57

Net cash from investing activities

(1,565)

(2,644)

Cash flows from financing activities

Share issue

1,968

2,995

Net cash from financing activities

1,968

2,995

(Decrease) in cash and cash equivalents

(30)

(75)

Cash and cash equivalents at

beginning of year

2

31

106

Cash and cash equivalents at end of

year

2

1

31

 

 

 

NOTES TO THE STATEMENTS OF CASH FLOWS

FOR THE YEAR ENDED 31 MAY 2013

 

1.

RECONCILIATION OF LOSS BEFORE INCOME TAX TO CASH GENERATED FROM OPERATIONS

Group & Company

 

2013

£'000

 

Company

 

2012

£'000

 

Loss before income tax

(446)

(477)

 

Depreciation charges

1

1

 

Finance costs

79

6

 

Finance income

(28)

(57)

 

Decrease/(increase) in value in investments

(248)

305

 

 

(642)

(222)

 

Increase in trade and other receivables

(2)

(35)

 

(Decrease)/increase in trade and other payables

290

(163)

 

Cash generated from operations

(354)

(420)

 

 

 

2. CASH AND CASH EQUIVALENTS

 

The amounts disclosed on the statement of cash flow in respect of cash and cash equivalents are in respect of these statement of financial position amounts:

 

Year ended 31 May 2013

31.5.13

1.6.12

£'000

£'000

Cash and cash equivalents

1

31

Year ended 31 May 2012

31.5.12

1.6.11

£'000

£'000

Cash and cash equivalents

31

106

 

 

 

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MAY 2013

 

1. ACCOUNTING POLICIES

 

Basis of preparation

These financial statements have been prepared in accordance with International Financial Reporting Standards and IFRIC interpretations and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS.

 

Craven House Capital plc is a company incorporated in the United Kingdom under the Companies Act. The address of the registered office is given on the company information page. The Company is listed on the AIM Market of the London Stock Exchange (code: CRV).

 

The financial statements have been prepared under the historical cost convention, except to the extent varied below for fair value adjustments required by accounting standards, and in accordance with applicable International Financial Reporting Standards (IFRS) as adopted for use by the European Union. The principal accounting policies are set out below.

 

These financial statements are presented in pounds sterling, rounded to the nearest £'000. Pounds sterling is the currency of the primary economic environment in which the company operates.

 

The accounting policies adopted by the Company are consistent with those of the previous financial year.

 

As at the date of approval of these financial statements some standards and interpretation were in issue but not yet effective. The directors expect that the adoption of those standards and interpretations in future accounting periods will not have a material impact on the company's results with the exception of 'Investment Entities (Amendments to IFRS 10 and 12 and IAS 27)': the Exposure Draft issued in October 2012 to be effective in relation to accounting periods beginning on or after 1 January 2014 is expected to be ratified by the EU before the end of 2013 and be available for early adoption thereafter. This will provide an exemption from the requirements of consolidation for investment entities and instead allow investment entities to present their investments in subsidiaries as a net investment measured at fair value. Although the application would not have impacted the Company's results in the year ended 31 May 2013, the Company expects to apply this exemption, where applicable, in future periods.

 

Basis of consolidation

The group financial information includes the financial information of Craven House Capital plc ('CRV') and its subsidiary undertaking, Craven House Industries Limited ('CHI'). CHI was incorporated during the year ended 31 May 2013 under the laws of the Republic of Ireland and as such, the 2012 figures presented relate to the Company only as no group existed as at 31 May 2012. CHI acts as an intermediate holding company for the Group's investment in Finishtec - Acabamentos Tecnicos em Metais Ltda - ME. CRV owns 95% of the issued share capital of CHI.

The consolidated financial statements incorporate the financial statements of the Company and entities controlled by the Company (its subsidiaries). Control is achieved where the Company has the power to govern the financial and operating policies of an entity so as to obtain benefits from its activities.

 

The results of subsidiaries acquired or disposed of during the year are included in the consolidated statement of comprehensive income from the effective date of acquisition and up to the effective date of disposal, as appropriate.

 

Where necessary, adjustments are made to the financial statements of subsidiaries to bring their accounting policies into line with those used by other members of the Group.

 

All intra-group transactions, balances, income and expenses are eliminated in full on consolidation.

 

Associates are those entities in which the Group has significant influence, but not control, over the financial and operating activities. Investments that are held as part of the Group's investment portfolio are carried in the balance sheet at fair value even though the Group may have significant influence over those companies. This treatment is permitted by IAS 28 - Investment in Associates, which requires investment held by venture organisations to be excluded from its scope where those investments are designated, upon initial recognition, as at fair value through profit or loss and accounted for in accordance with IAS 39, with changes in fair value recognised in the statement of comprehensive income in the period of change. The Group has no interests in associates through which it carries on its business.

 

Financial Assets

Purchases or sales of financial assets are recognised at the date of the transaction. Where appropriate criteria are met, the Company makes use of the option of designating fixed asset investments upon initial recognition as financial assets at fair value through profit or loss. These criteria include that the fixed asset investment should meet the Company's published Investing Policy and form part of the Company's managed portfolio or similar investments. Such financial assets are carried at fair value and movements in fair value are taken through the profit and loss account. For quoted securities, fair value is either the bid price or the last traded price, depending on the convention of the exchange on which the investment is quoted.

 

Measurement

 

Financial assets at fair value through profit or loss are initially recognised at fair value. Transaction costs are expensed through the profit or loss. Subsequent to initial recognition, all financial assets at fair value through profit or loss are measured at fair value in accordance with International Private Equity and Venture Capital Valuation ("IPEVCV") guidelines, as the Group's business is to invest in financial assets with a view to profiting from their total return in the form of capital growth and income. Gains and losses arising from changes in the fair value of the financial assets at fair value through profit or loss are presented in the period in which they arise.

 

Valuation of investments

 

Financial instruments that are measured subsequent to initial recognition at fair value are grouped into Levels 1 to 3 based on the degree to which the fair value is observable:

 

Level 1 fair value measurements are those derived from quoted prices (unadjusted) in active markets for identical assets or liabilities; and

 

Level 2 fair value measurements for those derived from inputs other than quoted prices included within Level 1 that are observable for the assets or liability, either directly or indirectly.

 

Level 3 fair value measurements are those derived from inputs that are not based on observable market data.

 

At the balance sheet date all of the Company's financial assets fell into Level 2 and Level 3.

 

a) Quoted investments

Where investments are quoted on recognised stock markets and an active market in the shares exists, the company values those investments at closing mid-market price on the reporting date. Where an active market does not exist those quoted investments are valued by the application of an appropriate valuation methodology as if the relevant investment was unquoted.

 

The carrying value of quoted investments at the balance sheet date was £887,682.

 

b) Unquoted investments

In estimating the fair value for an unquoted investment, the Company applies a methodology that is appropriate in light of the nature, facts and circumstances of the investment and its materiality in the context of the total investment portfolio using reasonable data, market inputs, assumptions and estimates. Any changes in the above data, market inputs, assumptions and estimates will affect the fair value of an investment which may lead to a recognition of an impairment loss in the statements of comprehensive income if an indication of impairment exists.

 

The carrying value of unquoted investments at the balance sheet date was £3,709,776.

 

Financial liabilities and equity

Financial liabilities are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the group after deducting all its liabilities.

 

Revenue recognition

Revenue recognition depends on the type of revenue concerned:

 

· Management fees are recognised as they are earned.

· Interest income and expense is recognised on an accruals basis as finance income.

· Investments are revalued periodically and any change in value recognised on the revaluation date as gross portfolio return.

 

The above policies on revenue recognition result in both deferred and accrued income.

 

Property, plant and equipment

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

 

Computer equipment

33% on cost

 

Taxation

The tax expense represents the sum of the tax currently payable and deferred tax at rates substantively enacted at the balance sheet date.

 

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The Company's liability for current tax is calculated using tax rates that have enacted by the balance sheet date.

 

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events that result in an obligation to pay more tax in the future or a right to pay less tax in the future have occurred at the balance sheet date. Timing differences between the Company's taxable profits and its results as stated in the financial information that arises from the inclusion of gains and losses in tax assessments in periods different from those in which they are recognised in the financial information.

 

Foreign currencies

In preparing the financial statements of the Company, transactions in currencies other than the entity's functional currency are recorded at the rates of exchange prevailing at the dates of the transactions. At each balance sheet date, monetary items denominated in foreign currencies are retranslated at the rates prevailing at the date when the fair value was determined. Non-monetary items that are measured in terms of historical cost in a foreign currency are not retranslated.

 

Exchange differences are recognised in profit or loss in the period in which they arise except for exchange differences on monetary items receivable from or payable to a foreign operation for which settlement is neither planned nor likely to occur; which form part of the net investment in a foreign operation and which are recognised in the foreign currency translation reserve.

 

For the purposes of presenting sterling financial statements, the assets and liabilities of the Company's foreign operations are expressed using exchange rates prevailing at the balance sheet date. Income and expense items are translated at the average exchange rate for the period, unless exchange rates fluctuated significantly during that period, in which case the exchange rates at the dates of the transactions are used. Exchange differences arising, if any, are classified as equity and recognised in a foreign currency translation reserve.

 

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to the profit and loss account on a straight line basis over the period of the lease.

 

Segment reporting

Operating segments are reported in a manner consistent with the internal reporting provided to the directors. The directors, who are responsible for allocating resources and assessing performance of the operating segments, have been identified as the senior management that make strategic decisions. The Company is principally engaged in investment business; the directors consider there is only one business segment significant enough for disclosure.

 

Critical accounting estimates and judgements

Preparation of financial statements in conformity with IFRS requires management to make judgements, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. The estimates and associated assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis of making judgements about carrying values of assets and liabilities that are not readily apparent from other sources.

 

In particular, significant areas of estimation, uncertainty and critical judgements in applying accounting policies that have the most significant effect on the amount recognised in the financial statements are in the following areas:

 

Valuation of investments

The Company has made a number of investments in the form of loans or equity instruments in private companies operating in emerging markets. The investee companies are generally at a key stage in their development and operating in an environment of uncertainty in capital markets. Should planned development prove successful, the value of the Company's investment is likely to increase, although there can be no guarantee that this will be the case. Should planned development prove unsuccessful, there is a material risk that the Company's investments may be impaired. The carrying amounts of investments are therefore highly sensitive to the assumption that the strategies of these investee companies will be successfully executed.

 

Going concern

At the balance sheet date, the Company had drawn down non-interest bearing loans from Desmond to enable it to make qualifying investments under its Investing Policy and to provide working capital for the Company. Although amounts drawn down are repayable within 12 months of the balance sheet date, Desmond has agreed that it will not seek repayment of outstanding balances in respect of both facilities unless the Company is in a position to make the repayment. Of the initial amount drawn down, £390,000 remained outstanding at the year end. The Directors also aim to generate cash from yield-based investments; and full / partial exits of the Company's more liquid investments (if required). Further to the successful private placing; the ongoing working capital facility provided by Desmond; and income generated by investments, the Board is pleased to report that the Company can prepare accounts on the going concern basis.

 

2. SEGMENTAL REPORTING

 

The operating segment has been determined and reviewed by the directors to be used to make strategic decisions. The directors consider there to be a single business segment being that of investing activities, therefore there is only one reportable segment.

 

 

3. EMPLOYEES AND DIRECTORS

Group & Company

Company

2013

2012

£'000

£'000

Wages and salaries - Directors' remuneration

34

72

 

The average monthly number of employees during the year was as follows:

 

2013

2012

£'000

£'000

Directors

3

4

 

Directors' remuneration was split as follows:

 

2013

2012

£'000

£'000

Fees

34

43

Share based payments

-

29

TOTAL

 

34

 

72

 

The highest paid director received emoluments and benefits as follows;

 

2013

2012

£'000

£'000

Fees

34

30

 

 

Desmond Holdings Ltd is the Company's Investment Manager. The directors are the key management of the Group. There were no directors (2012: none) to whom retirement benefits were accruing under money purchase schemes.

 

4. NET FINANCE INCOME

 

Group & Company

Company

2013

2012

£'000

£'000

Finance income:

Interest receivable

28

57

 

 

28

57

 

 

Finance costs:

 

Loan

79

6

 

Loan arrangement fee

-

-

 

 

79

6

 

 

Net finance income

(51)

51

 

 

 

5. LOSS BEFORE INCOME TAX

 

The loss before income tax is stated after charging/(crediting):

 

2013

£'000

2012

£'000

Rental charges

2

16

Depreciation - owned assets

1

1

Fees payable to the Company's auditor for the audit of the company's annual accounts

13

10

Fees payable to the Company's auditor for other services - tax services

5

-

-other services

2

-

Foreign exchange (gains) / losses

23

(15)

 

6. INCOME TAX

 

Analysis of charge in the year

2013

2012

£'000

£'000

Current tax:

UK corporation tax on profit of the year

-

-

Deferred tax

-

-

 

Tax on profit on ordinary activities

-

-

 

2013

2012

£'000

£'000

Loss on ordinary activities before tax

(446)

(477)

 

 

Analysis of charge in the year

Group & Company

 

2013

£'000

 

Company

 

2012

£'000

Profit on ordinary activities multiplied by small

(89)

(95)

 

Companies rate of corporation tax in the UK of

20% (2012:20%)

Effects of:

Loss carried forward

89

95

Current tax charge for the year as above

-

-

 

 

 

At 31 May 2013 the Company had UK tax losses of approximately £1,100,000 (2012: £597,000) available to be carried forward and utilised against future taxable profits. A deferred tax asset has not been recognised due to uncertainties over when profits will arise.

 

 

7. EARNINGS PER SHARE

 

Basic earnings per share is calculated by dividing the earnings attributable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period.

 

Diluted loss per share earnings per share has not been disclosed as the inclusion of unexercised warrants would be anti-dilutive.

 

Reconciliations are set out below.

 

2013

Earnings

£'000

Weighted average

number of shares

Per-share amount

pence

Basic EPS

Earning attributable to ordinary shareholders

(446)

510,107,834

-0.09

 

2012

Earnings

£'000

Weighted average

number of shares

Per-share amount

pence

Basic EPS

Earning attributable to ordinary shareholders

(477)

276,296,013

-0.17

 

 

8. PROPERTY, PLANT AND EQUIPMENT

 

 

Computer

equipment

£'000

COST

At 1 June 2012 - company

2

Additions

-

 

At 31 May 2013 - group and company

 

2

 

DEPRECIATION

At 1 June 2012 - company

1

Charge for year

1

 

At 31 May 2013 - group and company

 

2

 

NET BOOK VALUE

At 31 May 2012 - company

1

 

At 31 May 2013 - group and company

 

-

 

9.

INVESTMENTS

 

Investment in subsidiaries

 

During the year, the Company acquired 95% of the issued share capital of Craven House Industries Limited. The investment has been recognised at cost.

 

Investments at fair value through profit or loss

 

The Group adopted the recent investment methodology prescribed in the IPEVCV guidelines to value its investments at fair value through profit and loss.

 

The company has the following holdings at 31 May 2013:

 

Pressfit Holdings PLC

36.9%

Ceniako Limited

49.0%

Finishtec - Acabamentoss Tecnios em Metais Ltda.

47.5%

 

 

Investments that are held as part of the Group's investment portfolio are carried in the balance sheet at fair value even though the Group may have significant influence over those companies. This treatment is permitted by IAS 28 - Investment in Associates, which requires investment held by venture organisations to be excluded from its scope where those investments are designated, upon initial recognition, as at fair value through profit or loss and accounted for in accordance with IAS 39, with changes in fair value recognised in the statement of comprehensive income in the period of change. The Group has no interests in associates through which it carries on its business.

 

Investments at fair value through profit or loss

 

 

Group

Quoted investments

£'000

 

Unquoted investments

£'000

 

Totals

£'000

 

At 1 June 2011

-

486

486

Additions

1,208

1,528

2,736

Disposals

-

(61)

(61)

Revaluations

(375)

70

(305)

Effect of foreign exchange

-

30

30

 

 

At 31 May 2012

 

833

 

 

2,053

 

2,886

Additions

-

2,018

2,018

Disposals

(100)

(437)

(537)

Revaluations

154

94

248

Effect of foreign exchange

-

(18)

(18)

 

 

At 31 May 2013

 

 

887

 

3,710

 

4,597

 

Company

Quoted investments

£'000

Unquoted investments

£'000

 

Totals

£'000

At 1 June 2011

-

486

486

Additions

1,208

1,528

2,736

Disposals

-

(61)

(61)

Revaluations

(375)

70

(305)

Effect of foreign exchange

-

30

30

 

At 31 May 2012

 

833

 

2,053

 

2,886

 

Additions

-

1,362

1,362

Disposals

(100)

(437)

(537)

Revaluations

154

94

248

Effect of foreign exchange

-

(18)

(18)

 

At 31 May 2013

 

887

 

3,054

 

3,941

 

 

 

Unquoted investments - Group

 

 

Equity

£'000

 

Convertible loans

£'000

 

Distressed loan

£'000

 

 

 Total

£'000

 

 

At 1 June 2011

-

486

-

486

Additions

1,433

95

-

1,528

Disposals

-

(61)

-

(61)

Revaluations

41

29

-

70

Effect of foreign exchange

-

30

-

30

At 31 May 2012

1,474

579

-

2,053

Additions

1,419

-

599

2,018

Disposals

-

(437)

-

(437)

Revaluations

94

-

-

94

Effect of foreign exchange

-

(18)

-

(18)

At 31 May 2013

2,987

124

599

3,710

 

Unquoted investments - Company

 

 

Equity

£'000

 

Convertible loans

£'000

 

Distressed loan

£'000

 

 

 Total

£'000

 

 

At 1 June 2011

-

486

-

486

Additions

1,433

95

-

1,528

Disposals

-

(61)

-

(61)

Revaluations

41

29

-

70

Effect of foreign exchange

-

30

-

30

At 31 May 2012

1,474

579

-

2,053

Additions

763

-

599

1,362

Disposals

-

(437)

-

(437)

Revaluations

94

-

-

94

Effect of foreign exchange

-

(18)

-

(18)

At 31 May 2013

2,331

124

599

3,054

 

 

Quoted investments at 31 May 2013 relate to shares held in Farm Lands of Africa Inc, a company listed on the OTC markets in New York. These shares have been measured on a Level 2 basis due to these not being traded in an active market.

 

Unquoted investments at 31 May 2013 have been measured on a Level 3 basis as no observable market data was available. These investments are as follows:

 

Shares in Pressfit Holdings Plc are valued at £178,156, representing a 36.9% holding. These have been valued at the latest transaction price paid by Craven House Capital as the Directors believe this is the best information available and they are not aware of any circumstances to indicate an impairment of this investment.

 

Shares in Ceniako Limited valued at £856,262, representing a 49% holding. These have been valued at the price paid by Craven House Capital during the year as the Directors believe that this is the best indication of the value at the year end.

 

Shares in Finishtec Acabamento Tecnicos em Matais Ltda valued at £656,462. This is held through a 95% subsidiary Craven House Industries Limited giving the group a 47.6% stake. These have been valued at the price paid by Craven House Capital during the year as the Directors believe that this is the best indication of the value at the year end.

 

A convertible loan to Pressfit Holdings Plc valued at £123,501. This has been valued based on the number of shares that Craven House Capital would receive on conversion at the same market price as the shares held above as these can be converted at any time at Craven's option.

 

A distressed loan with Greentel Limited valued at £599,382. The year end valuation is based on the price paid for the loan on 28 May 2013 which the Directors believe is the most appropriate indicator of the year end valuation based on the information available to them.

 

10. TRADE AND OTHER RECEIVABLES

 

Group & Company 2013

£'000

Company 2012

£'000

 

 

 

Current:

 

Trade debtors

6

16

 

Other debtors

54

3

 

Prepayments and accrued income

19

58

 

 

79

77

 

 

 

11. CASH AND CASH EQUIVALENTS

 

2013

£'000

2012

£'000

Bank accounts

1

31

 

 

 

12. CALLED UP SHARE CAPITAL

 

Authorised

Equity shares

 

Number

Class

Nominal Value:

2013

£'000

2012

£'000

 

2,280,038,212

Ordinary

0.001

2,280

2,280

77,979,412

Deferred

0.09

7,018

7,018

77,979,412

Deferred

0.009

702

702

 

10,000

 

10,000

Alloted, called up and fully paid

Equity Shares

 

Number

Class

Nominal value

2013

£'000

2012

£'000

 

592,695,949

(2012: 435,145,211)

Ordinary

0.001

593

296

77,979,412

Deferred

0.09

7,018

7,018

77,979,412

Deferred

0.009

702

702

8,313

 

8,016

The deferred shares carry no entitlement to receive notice of any general meeting, to attend, speak or vote at such general meeting. Holders are not entitled to receive dividends, and on a winding up of the Company holders of deferred shares are entitled to a return of capital only after the holder of each Ordinary share has received a return of capital together with a payment of £1 million per share. The deferred shares may be cancelled at any time for no consideration by way of a reduction in capital.

 

On 24 September 2012, the Company issued 62,891,520 new ordinary shares to various existing shareholders of Ceniako Limited for a consideration of $1,000,000 (£786,144).

 

On 2 January 2013, the Company allotted 49,739,760 new ordinary shares to various existing shareholders of Finishtec-Acabamentos Tecnicos em Metais Ltda for a consideration of $1,000,000 (£621,747).

 

On 28 February 2013, the Company allotted 44,189,458 new ordinary shares to Desmond Holdings Ltd in lieu of the performance fee due for the year ended 31st May 2012, the value of the performance fee being £552,368.

 

On 28 February 2013, the Company allotted 730,000 new ordinary shares to Mr. Michael Pajak in lieu of services rendered totalling £9,125.

 

13. TRADE AND OTHER PAYABLES

 

Group & Company 2013

£'000

Company 2012

£'000

 

Current:

184

15

 

Trade creditors

188

65

 

Accruals and deferred income

-

2

 

372

82

 

 

14.

FINANCIAL LIABILITIES - BORROWINGS

 

2013

£'000

2012

£'000

Current:

 

Other loans

463

593

 

 

1 year or less

£'000

 

Other loans

463

 

 

 

Other loans of £463,000 comprise advances made by Desmond Holdings Ltd ("Desmond") totalling £390,000 and loans made by Wise Star Capital Investment Limited, both being Hong Kong investment companies. The loans were provided to enable the Company to make qualifying investments under its Investing Policy and to provide working capital for the Company.

 

The terms of the loans provided by Desmond are as follows:

 

a) Investment facility

Non-interest bearing loan facility of up to £700,000, originally provided in December 2010. The majority of this has now been repaid and as at 31 May 2013, the Company's borrowings under this facility totalled £56,000.

 

b) Working capital loans

Interest-bearing loans provide financial support to enable the Company to meet its reasonable working capital requirements. The facility will remain in place for at least 12 months from the date of approval of the financial statements. Desmond has agreed that it will not seek repayment of outstanding balances in respect of both facilities unless the Company is in a position to make the repayment.

 

The loan provided by Wise Star Capital Investment Limited includes interest payable at a rate of 6% per annum. The loan was provided for 12 months dated 1st September 2011; however this loan has since been extended by a further 12 months. The amount owed to Wise Star Capital Investment Limited at the balance sheet date was £72,206.

 

15. FINANCIAL INSTRUMENTS

 

Financial risk management objectives and policies

 

Management has adopted certain policies on financial risk management with the objective of:

i. ensuring that appropriate funding strategies are adopted to meet the Company's short-term and long-term funding requirements taking into consideration the cost of funding, gearing levels and cash flow projections;

 

ii. ensuring that appropriate strategies are also adopted to manage related interest and currency risk funding; and

 

iii. ensuring that credit risks on receivables are properly managed.

 

Financial instrument by category

 

The accounting policies for financial instruments have been applied to the line items below:

 

Financial assets at fair value through profit or loss

 

Financial instruments that are measured subsequent to initial recognition at fair value are grouped into Levels 1 to 3 based on the degree to which the fair value is observable:

 

Level 1 fair value measurements are those derived from quoted prices (unadjusted) in active markets for identical assets or liabilities; and

 

Level 2 fair value measurements for those derived from inputs other than quoted prices included within Level 1 that are observable for the assets or liability, either directly or indirectly.

 

Level 3 fair value measurements are those derived from inputs that are not based on observable market data.

 

At the balance sheet date all of the Company's financial assets fell into Level 2 and Level 3.

 

Carrying values of all financial assets and liabilities approximate to fair values. They are neither past due nor impaired.

 

Credit risk

 

The Company's credit risk is primarily attributable to other receivables. Management has a credit policy in place and the exposure to credit risks is monitored on an ongoing basis. In respect of other receivables, individual credit evaluations are performed whenever necessary. The Company's maximum exposure to credit risk is represented by the total financial assets held by the Company.

 

Interest rate risk

 

The Company currently operates with positive cash and cash equivalents as a result of issuing share capital in anticipation of future funding requirements. As the Company has no borrowings from the bank and the amount of deposits in the bank are not significant, the exposure to interest rate risk is not significant to the company. The effect of a 10% increase or fall in interest rates obtainable on cash and on short-term deposits would be to increase or decrease the Company's profit by less than £1,000 (2012: Less than £1,000).

 

Liquidity risk

 

The Company manages its liquidity requirements by the use of both short-term and long-term cash flow forecasts. The Company's policy to ensure facilities are available as required is to issue equity share capital in accordance with agreed settlement terms with vendors or professional firms, and all are due within one year.

 

Price risks

 

The Company's securities are susceptible to price risk arising from uncertainties about future value of its investments. This price risk is the risk that the fair value of future cash flows will fluctuate because of changes in market prices, whether those changes are caused by factors specific to the individual investment or financial instrument or its holder or factors affecting all similar financial instruments or investments traded in the market.

 

During the year under review, the Company did not hedge against movements in the value of its investments. A 10% increase/decrease in the fair value of investments would result in a £89,000 (2012: £80,000) increase/decrease in the net asset value.

 

While investments in companies whose business operations are based in emerging markets may offer the opportunity for significant capital gains, such investments also involve a degree of business and financial risk, in particular for quoted investments.

 

Generally, the Company is prepared to hold unquoted investments for a middle to long time frame, in particular if an admission to trading on a stock exchange has not yet been planned. Sale of securities in unquoted investments may result in a discount to the book value.

 

Currency risks

 

As investments may be made in foreign currencies (primarily US$), the Company is exposed to the risk of unrealised losses on retranslation into the reporting currency at reporting dates and to realised losses on realisations of investments denominated in foreign currencies. There is no systematic hedging in foreign currencies against such possible losses on translation/realisation.

 

Otherwise the Company operates primarily within its local currency.

 

Capital management

 

The Company's financial strategy is to utilise its resources to further grow its portfolio. The Company keeps investors and the market informed of its progress with its portfolio through regular announcements and raises additional equity finance at appropriate times.

 

The Company regularly reviews and manages its capital structure for the portfolio companies to maintain a balance between the higher shareholder returns that might be possible with certain levels of borrowing for the portfolio and the advantages and security afforded by a sound capital position, and makes adjustments to the capital structure of the portfolio in the light of changes in economic conditions. Although the Company has utilised loans from shareholders to acquire investments, it is the Company's policy as far as possible to finance its investing activities with equity and not to have gearing in its portfolio.

 

At the balance sheet date the capital structure of the Company consisted of borrowings disclosed in note 14, cash and cash equivalents and equity comprising issued capital and reserves.

 

16. RELATED PARTY DISCLOSURES

 

During the year, the Company entered into the following transactions with related parties and connected parties:

 

Loans from Desmond Holdings Limited

At the year end the Company owed £390,000 to Desmond Holdings Limited, the Company's Investment Manager and major shareholder in the Company. Details of the loan are set out in note 14.

 

Management fees payable to Desmond Holdings Limited

At the year end, included in trade creditors, is an amount of £52,500 payable to Desmond Holdings Limited, in respect of management services provided in the year. The total amount owed to Desmond in respect of unpaid invoices at the balance sheet date was £122,500.

 

Performance fee payable to Desmond Holdings Limited

At the year end, included in accruals and deferred income is an amount of £170,600 payable to Desmond Holdings Limited in respect of the performance fee due for the year. The performance fee calculation is based on the increase in net asset value per share in the year. Payment of the performance fee will be by way of shares issued in the company. These shares had not yet been issued at 31st May 2013.

 

Investment in Pressfit Holdings Plc

At the year end the Company held shares in Pressfit Holdings Plc and a convertible loan was owed to the company, both of which were included in unquoted investments as detailed in note 9. During the year Mark Pajak was appointed as Chairman of Pressfit Holdings Plc.

 

Directors and key management

Amounts payable in the year to directors (who also comprise key management) are set out in the Directors' Remuneration report. At 31 May 2013 the following amounts were payable to directors:

 

Mark Pajak

-

Alexandra Eavis

-

Balbir Bindra

£9,000

 

As disclosed in the Directors' Remuneration report the payment to Balbir Bindra will be by way of shares issued in the company. These shares had not yet been issued at 31st May 2013.

 

All key management personnel are directors and appropriate disclosure with respect to them is made in note 3 of the financial statements. There are no other contracts of significance in which any director has or had during the year a material interest.

 

17. EVENTS AFTER THE REPORTING PERIOD

 

On 29 July 2013, Pressfit entered into a Partnership Agreement with GXM (Amcopress) Group Co., Limited ("AMCO"). As part of the Partnership Agreement, AMCO agreed to invest £1,575,000 into Pressfit by way of a convertible loan note. This loan was converted in September 2013, resulting in AMCO now holding 45.1% of Pressfit's enlarged share capital, with Craven House's holding reduced to 20.3% of the enlarged share capital (or 21.6% if Craven House converts its own convertible loan note). Further to shareholder approval received at its AGM / EGM on 30 August 2013, Pressfit also began preparations for an introduction to the AIM market.

 

On 1 August 2013, the Company completed a settlement agreement with Farm Lands of Africa Inc. ("FLAF") ("Settlement Agreement"). As a result of the settlement, Craven House now holds a 50% stake in Farm Lands of Africa Ltd ("FLAL"), a BVI registered company, which owns 90% of Land and Resources (Guinea) SA ("LRG"). The completion of the Settlement Agreement has resulted in Craven House receiving $60,000 cash and 20,000,000 shares in FLAL BVI (equal to 45% of total issued share capital).

 

On the 4th November 2013, the Company acquired a 49% shareholding in a portfolio of agricultural and food processing businesses in South Africa, for a total consideration of $1,960,000. This portfolio comprises a 1,017 hectare vegetable and cattle farm, a vegetable dehydration factory and a distribution centre.

 

The restructuring of the distressed loan on the Green Isle Conference and Leisure Hotel in Dublin was completed 21st November 2013. During the period, the Company acquired the Loan for €0.7 million, becoming the sole secured lender for the Hotel. The sale of the Hotel to the new owners has now been completed, and the Company has agreed with the new owners to convert the Loan into a mortgage of €1.5 million. The Mortgage will carry an interest rate of 4% per annum and will be repaid in full within three years.

 

In order to acquire the Loan originally, the Company also took on a loan of €0.7 million from Desmond Holdings Ltd. At the time the Hotel was purchased, there was a significant amount of outstanding interest on the Loan. The Company has been able to recover this interest and used it to repay the Desmond Loan.

 

The combination of the uplift in value from the Loan to the Mortgage, and the repayment of the Desmond Loan is expected to result in an increase of €1.5 million in the net asset value of Craven House.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR UWAURONAAUUA
Date   Source Headline
28th Feb 20247:00 amRNSInterim Results
4th Jan 20247:00 amRNSResult of Annual General Meeting
29th Nov 20232:48 pmRNSAnnual Results for year ended 31 May 2023
28th Nov 20234:08 pmRNSInvestee Companies' Update
16th Nov 20239:07 amRNSInvestee Companies’ Update: Garimon and Honeydog
23rd Oct 20237:00 amRNSInvestee company update: Bio Vitos
17th Oct 20237:46 amRNSInvestee Companies’ Update: Garimon and Honeydog
29th Aug 20231:34 pmRNSInvestee company update: Bio Vitos
3rd Jul 20231:32 pmRNSInvestee company update: Bio Vitos
3rd Mar 20236:15 pmRNSPortfolio Update
27th Feb 20233:30 pmRNSInterim Results
8th Feb 20237:00 amRNSInvestee company update: Bio Vitos
27th Jan 202311:33 amRNSResult of Annual General Meeting
29th Nov 20227:00 amRNSAnnual Results for Year Ended 31 May 2022
15th Nov 20222:42 pmRNSInvestee company update: Garimon Ltd
23rd Feb 20223:01 pmRNSInterim Results
21st Jan 202212:45 pmRNSResult of AGM
23rd Dec 20213:59 pmRNSNotice of AGM
29th Nov 20216:29 pmRNSAnnual Results for year ended 31 May 2021
24th Nov 20212:55 pmRNSInvestee company update: OneBas.Com Ltd.
26th Oct 20217:00 amRNSInvestee company update: YRRO Ltd
16th Mar 20211:06 pmRNSTR-1: Notification of major holdings
18th Feb 20213:07 pmRNSInterim Results
11th Feb 202111:21 amRNSTR-1: Notification of major holdings
5th Feb 202110:44 amRNSStatement Regarding Share Price Movement
18th Jan 20212:49 pmRNSResult of Annual General Meeting
21st Dec 20207:00 amRNSNotice of General Meeting
9th Dec 20207:00 amRNSInvestee Company Update: YRRO Ltd
3rd Dec 202012:43 pmRNSAnnual Results for year ended 31 May 2020
9th Nov 20209:45 amRNSChange of Auditor
9th Oct 20203:14 pmRNSTrading Update, Change of Auditor & 2020 Results
18th Sep 202010:57 amRNSInvestee company update: Magazinos.com
22nd Jun 20201:01 pmRNSTR-1: Notification of major holdings
18th Jun 202011:06 amRNSSecond Price Monitoring Extn
18th Jun 202011:00 amRNSPrice Monitoring Extension
3rd Jun 20201:27 pmRNSTR-1: Notification of major holdings
1st Jun 20202:05 pmRNSSecond Price Monitoring Extn
1st Jun 20202:00 pmRNSPrice Monitoring Extension
22nd May 20209:43 amRNSResult of General Meeting
5th May 202010:42 amRNSTR-1: Notification of major holdings
1st May 202010:58 amRNSPosting of Circular
1st Apr 20203:39 pmRNSCoronavirus and Business Update
23rd Mar 202012:19 pmRNSOn-line Platform Launched by Investee, Rosedog Ltd
20th Mar 20205:01 pmRNSNotification of major holdings
13th Mar 20207:00 amRNSSimultaneous exercise of five Option Agreements
27th Feb 202011:22 amRNSIssue of Equity and Directors' Dealing
27th Feb 20207:00 amRNSInterim Results
25th Feb 20209:16 amRNSNotification of major holdings
24th Feb 20207:00 amRNSCraven House signs 5 Non-binding Option Agreements
18th Feb 20202:54 pmRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.